A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings
- PMID: 25666221
- PMCID: PMC4441669
- DOI: 10.1007/s11606-015-3214-9
A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings
Abstract
Background: Decision support interventions (DESIs) provide a mechanism to translate comparative effectiveness research results into clinical care so that patients are able to make informed decisions. Patient decision support interventions for prostate-specific antigen (PSA) have been shown to promote informed decision making and reduce PSA testing in efficacy trials, but their impact in real world settings is not clear.
Objective: We performed an effectiveness trial of PSA decision support interventions in primary care.
Design: A randomized controlled trial of three distribution strategies was compared to a control.
Participants: Participants included 2,550 men eligible for PSA testing (76.6 % of the eligible population) and 2001 survey respondents (60.1 % survey response rate).
Interventions: The intervention groups were: 1) mailed the DESI in DVD format, 2) offered a shared medical appointment (SMA) to view the DESI with other men and discuss, and 3) both options.
Main measures: We measured PSA testing identified via electronic medical record at 12 months and DESI use by self-report 4 months after the intervention mailing.
Key results: We found no differences in PSA testing across the three distribution strategies over a year-long follow-up period: 21 %, 24 %, 22 % in the DESI, SMA, and combined group respectively, compared to 21 % in the control group (p = 0.51). Self-reported DESI use was low across all strategies at 4 months: 16 % in the mailed DESI group, 6 % in the SMA group, and 15 % in the combined group (p = < 0.0001).
Conclusions: Mailing PSA decision support interventions or inviting men to shared medical appointments unrelated to a primary care office visit do not appear to promote informed decision making, or change PSA testing behavior.
Trial registration: ClinicalTrials.gov NCT01241656.
Figures
Comment in
-
Delivering a decision support intervention about PSA screening to patients outside of clinical encounters is ineffective in promoting informed decision-making.Evid Based Med. 2015 Aug;20(4):139. doi: 10.1136/ebmed-2015-110196. Epub 2015 Jun 2. Evid Based Med. 2015. PMID: 26041793 No abstract available.
References
-
- Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;10 - PubMed
-
- Centers for Disease Control and Prevention. http://www.cdc.gov/cancer/prostate/basic_info/screening.htm. Accessed Jan 23 2015.
-
- National Cancer Institute FactSheet: Prostate-Specific Antigen (PSA) Test. National Cancer Instititute. 2012. http://www.cancer.gov/cancertopics/factsheet/detection/PSA. Accessed Jan 23 2015.
-
- American Cancer Society recommendations for prostate cancer early detection. American Cancer Society. 2012. http://www.cancer.org/cancer/prostatecancer/moreinformation/prostatecanc.... Accessed Jan 23 2015.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
